This inventor holds 5 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignees: Obsidian Therapeutics, Inc., Intellia Therapeutics, Inc., Novartis Ag. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 9 
1 out of 20 
1 out of 3,978 
Years Active: 2021-2026
Title: Celeste Richardson: Innovator in Immuno-Oncology
Introduction
Celeste Richardson is a prominent inventor based in Brookline, MA (US), known for her significant contributions to the field of immuno-oncology. With a total of four patents to her name, she has made remarkable strides in developing innovative solutions for cancer treatment.
Latest Patents
Her latest patents include "Compositions and methods for immunooncology," which focuses on genome editing systems, reagents, and methods aimed at enhancing immuno-oncology therapies. Another notable patent is "PDE5 compositions and methods for immunotherapy," which relates to the regulated and controlled expression of proteins to induce anti-cancer immune responses in subjects.
Career Highlights
Throughout her career, Celeste has worked with leading companies in the pharmaceutical industry, including Obsidian Therapeutics, Inc. and Novartis AG. Her work has been instrumental in advancing therapeutic approaches that leverage the body's immune system to combat cancer.
Collaborations
Celeste has collaborated with esteemed colleagues such as Vipin Suri and Dexue Sun, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Celeste Richardson's work in immuno-oncology exemplifies the impact of innovative thinking in the fight against cancer. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile